![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:1351715 | 6480464 | epigallocatechin gallate results in increased expression of RAB15 protein | CTD | PMID:31195006 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1332034 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of RAB15 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1332034 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RAB15 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | RGD:1351715 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of RAB15 mRNA | CTD | PMID:17404688 | 17beta-estradiol | increases expression | ISO | RGD:1332034 | 6480464 | Estradiol results in increased expression of RAB15 mRNA | CTD | PMID:19484750 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1332034 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RAB15 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RAB15 mRNA | CTD | PMID:33387578 | 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of RAB15 mRNA | CTD | PMID:23537331 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1332034 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of RAB15 mRNA | CTD | PMID:20188158 | 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | decreases expression | ISO | RGD:1351715 | 6480464 | Am 580 results in decreased expression of RAB15 mRNA | CTD | PMID:16982809 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of RAB15 mRNA | CTD | PMID:24780913 | all-trans-retinoic acid | decreases expression | ISO | RGD:1351715 | 6480464 | Tretinoin results in decreased expression of RAB15 mRNA | CTD | PMID:33167477 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of RAB15 mRNA | CTD | PMID:16483693 | arsenous acid | increases expression | ISO | RGD:1351715 | 6480464 | Arsenic Trioxide results in increased expression of RAB15 mRNA | CTD | PMID:20458559 | arsenous acid | decreases expression | ISO | RGD:1351715 | 6480464 | Arsenic Trioxide results in decreased expression of RAB15 mRNA | CTD | PMID:22521957 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of RAB15 mRNA | CTD | PMID:21839799 | benzo[a]pyrene | affects methylation | ISO | RGD:1351715 | 6480464 | Benzo(a)pyrene affects the methylation of RAB15 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:1351715 | 6480464 | Benzo(a)pyrene results in increased expression of RAB15 mRNA | CTD | PMID:22316170 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RAB15 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RAB15 mRNA | CTD | PMID:30816183 more ... | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of RAB15 gene | CTD | PMID:28505145 | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of RAB15 mRNA | CTD | PMID:19167457 | chlordecone | increases expression | ISO | RGD:1332034 | 6480464 | Chlordecone results in increased expression of RAB15 mRNA | CTD | PMID:33711761 | choline | multiple interactions | ISO | RGD:1332034 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RAB15 mRNA | CTD | PMID:20938992 | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of RAB15 mRNA | CTD | PMID:20187946 | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of RAB15 mRNA | CTD | PMID:26577399 | cyclosporin A | decreases expression | ISO | RGD:1351715 | 6480464 | Cyclosporine results in decreased expression of RAB15 mRNA | CTD | PMID:20106945, PMID:25562108 | diarsenic trioxide | increases expression | ISO | RGD:1351715 | 6480464 | Arsenic Trioxide results in increased expression of RAB15 mRNA | CTD | PMID:20458559 | diarsenic trioxide | decreases expression | ISO | RGD:1351715 | 6480464 | Arsenic Trioxide results in decreased expression of RAB15 mRNA | CTD | PMID:22521957 | dichlorine | increases expression | EXP | | 6480464 | Chlorine results in increased expression of RAB15 mRNA | CTD | PMID:18636392 | dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] affects the expression of RAB15 mRNA | CTD | PMID:18636392 | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of RAB15 mRNA | CTD | PMID:21551480 | dorsomorphin | multiple interactions | ISO | RGD:1351715 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB15 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | RGD:1351715 | 6480464 | Doxorubicin results in decreased expression of RAB15 mRNA | CTD | PMID:29803840 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of RAB15 mRNA | CTD | PMID:29391264 | ethanol | multiple interactions | ISO | RGD:1332034 | 6480464 | Ethanol affects the expression of and affects the splicing of RAB15 mRNA | CTD | PMID:30319688 | ferric oxide | increases expression | ISO | RGD:1332034 | 6480464 | ferric oxide analog results in increased expression of RAB15 mRNA | CTD | PMID:25086211 | folic acid | multiple interactions | ISO | RGD:1332034 | 6480464 | [1 more ... | CTD | PMID:20938992, PMID:22206623 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of RAB15 mRNA | CTD | PMID:27387713 | genistein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Methoxychlor] results in increased expression of RAB15 mRNA | CTD | PMID:21782745 | genistein | decreases expression | ISO | RGD:1332034 | 6480464 | Genistein results in decreased expression of RAB15 mRNA | CTD | PMID:32186404 | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of RAB15 mRNA | CTD | PMID:21782745 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of RAB15 mRNA | CTD | PMID:33387578 | ivermectin | decreases expression | ISO | RGD:1351715 | 6480464 | Ivermectin results in decreased expression of RAB15 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | RGD:1332034 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RAB15 mRNA | CTD | PMID:20938992 | lead(0) | affects expression | ISO | RGD:1351715 | 6480464 | Lead affects the expression of RAB15 mRNA | CTD | PMID:28903495 | lead(2+) | affects expression | ISO | RGD:1351715 | 6480464 | Lead affects the expression of RAB15 mRNA | CTD | PMID:28903495 | methoxychlor | increases expression | EXP | | 6480464 | Methoxychlor results in increased expression of RAB15 mRNA | CTD | PMID:21782745 | methoxychlor | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Methoxychlor] results in increased expression of RAB15 mRNA | CTD | PMID:21782745 | ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] affects the expression of RAB15 mRNA | CTD | PMID:18636392 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of RAB15 mRNA | CTD | PMID:33387578 | phenethyl isothiocyanate | affects binding | ISO | RGD:1351715 | 6480464 | RAB15 protein binds to phenethyl isothiocyanate | CTD | PMID:21838287 | progesterone | multiple interactions | ISO | RGD:1351715 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of RAB15 mRNA | CTD | PMID:17404688 | progesterone | decreases expression | ISO | RGD:1351715 | 6480464 | Progesterone results in decreased expression of RAB15 mRNA | CTD | PMID:21540246 | SB 431542 | multiple interactions | ISO | RGD:1351715 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB15 mRNA | CTD | PMID:27188386 | silver atom | decreases expression | ISO | RGD:1332034 | 6480464 | Silver results in decreased expression of RAB15 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | RGD:1332034 | 6480464 | Silver results in decreased expression of RAB15 mRNA | CTD | PMID:27131904 | sunitinib | decreases expression | ISO | RGD:1351715 | 6480464 | Sunitinib results in decreased expression of RAB15 mRNA | CTD | PMID:31533062 | temozolomide | increases expression | ISO | RGD:1351715 | 6480464 | Temozolomide results in increased expression of RAB15 mRNA | CTD | PMID:31758290 | tetrachloromethane | affects expression | ISO | RGD:1332034 | 6480464 | Carbon Tetrachloride affects the expression of RAB15 mRNA | CTD | PMID:17484886 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of RAB15 mRNA | CTD | PMID:34492290 | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of RAB15 gene | CTD | PMID:27618143 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of RAB15 mRNA | CTD | PMID:33387578 | triptonide | increases expression | ISO | RGD:1332034 | 6480464 | triptonide results in increased expression of RAB15 mRNA | CTD | PMID:33045310 | tris(2-butoxyethyl) phosphate | affects expression | ISO | RGD:1351715 | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of RAB15 mRNA | CTD | PMID:29024780 | valproic acid | increases methylation | ISO | RGD:1351715 | 6480464 | Valproic Acid results in increased methylation of RAB15 gene | CTD | PMID:29154799 | valproic acid | multiple interactions | ISO | RGD:1351715 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB15 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | RGD:1351715 | 6480464 | Valproic Acid results in increased expression of RAB15 mRNA | CTD | PMID:19101580 more ... | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of RAB15 mRNA | CTD | PMID:19015723 | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of RAB15 gene | CTD | PMID:31079544 | |